Key result
Cardiac contractility modulation is linked to improved GLS, LVEF, and quality of life in HFrEF.
Why the study?
There was no data available on whether cardiac contractility modulation (CCM) leads to changes in left ventricular global longitudinal strain (GLS) in patients with HFrEF.
Does cardiac contractility modulation improve left ventricular global longitudinal strain and ejection fraction in patients with chronic heart failure?
Cohort (n=22)
Does cardiac contractility modulation improve left ventricular global longitudinal strain and ejection fraction in patients with chronic heart failure?
Answers are grounded in this paper and cite their sources.
Cardiac contractility modulation therapy significantly improves left ventricular global longitudinal strain, ejection fraction, and quality of life in patients with HFrEF.
Background: Cardiac contractility modulation (CCM) is a therapy for patients with chronic heart failure with reduced ejection fraction (HFrEF). However, so far, there is no data available as to whether the application of CCM leads to changes in left ventricular global strain (GLS). This might be of special interest because GLS is known to be a strong predictor of outcomes in patients with HFrEF. Methods: Patients over 18 years old with heart failure with impaired left ventricular function (LVEF < 45%), a QRS complex < 130 ms, and NYHA classes II–IV despite guideline-directed medical therapy who planned to receive CCM implantation within 6 months were prospectively included into this study. Every 3 months, the status regarding CCM therapy was determined, and a standardized echocardiographic examination including the determination of LV global longitudinal strain was performed. Results: Between 30.12.2021 and 10.09.2024, 22 consecutive patients were prospectively enrolled in the study. CCM implantation was performed for 19 patients at a mean time of 59 ± 65 days. Under active CCM therapy, there was an improvement in GLS, LV-EF, and the Kansas City Heart Failure Questionnaire (KCCQ; all p < 0.05). A linear regression analysis showed that the positive effect of CCM on GLS was especially pronounced in patients with a female sex, a non-ischemic etiology of heart failure, and age ≤ 69 years, respectively (all p < 0.05). Conclusions: CCM therapy is not only linked to an improvement in LV-EF but also increases the global longitudinal strain and quality of life of patients with HFrEF.
No takes yet. Share an insight, caveat, or question.
Raab et al. (2025) conducted a cohort in Chronic heart failure with reduced ejection fraction (HFrEF) (n=22). Cardiac contractility modulation (CCM) was evaluated on Left ventricular global longitudinal strain (GLS), LV-EF, and Kansas City Heart Failure Questionnaire (KCCQ) (p=<0.05). Cardiac contractility modulation therapy improved global longitudinal strain, left ventricular ejection fraction, and quality of life in patients with HFrEF.
Synapse has enriched 10 related papers. Consider them for comparative context: